Boo Samra - Why join Parexel as a CRA in Japan?

Doing it With Heart™ - Parexel employees share how they work With Heart™

Patients first - Parexel employees share how they work with the patients in mind

Working With Heart™ as a Clinical Operations Leader at Parexel

Accelerating early phase development in the UK and Germany

Working With Heart™ - Jo's Regulatory Consultant perspective

Working With Heart™ - Sheila's Clinical Operations Leaders Perspective

Part 5: Pioneering new approaches, technologies, and AI to drive innovation

Part 4: The impact of the Inflation Reduction Act

Part 6: Generating investor interest

Part 2: How pharma is using M&A for growth and innovation

Part 1: Future predictions

Part 3: Regulatory dynamics and research trends

About Parexel Japan - Hear from Mutsukuni Kataoka, Executive Director, Clinical Operations Japan

Working With Heart™ - Christina's Clinical Operations Manager Perspective

Parexel’s Clinical Trial Supplies & Logistics Solution

Leveraging machine-learned predictive analytics to help answer a series of questions

Bayesian networks predictive modelling: Machine learning approach for individualized risk prediction

Overview of AI applications in HEOR and market access

Regulatory, data privacy and security aspects to consider with the use of AI

Expedite payer coverage with surrogate endpoints

How to describe Parexel's culture in one word

Patients first - Parexel employees share how they work with the patients in mind

Boo Samra - Why join Parexel as a CRA in Japan?

6 considerations in Alzheimer’s Disease drug development